Tower Research Capital LLC (Trc) Innate Pharma Sa Transaction History

Tower Research Capital LLC (Trc)

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$1.9 - $3.73 $5,612 - $11,018	2,954 New	2,954 $11,000
Q2 2022 Aug 15, 2022	BUY	$2.0 - $3.55 $5,200 - $9,230	2,600 New	2,600 $7,000
Q1 2022 May 12, 2022	SELL	$2.7 - $4.8 $1,107 - $1,968	-410 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.34 - $6.06 $29,512 - $41,208	-6,800 Reduced 94.31%	410 $2,000
Q3 2021 Nov 15, 2021	BUY	$3.04 - $8.1 $21,918 - $58,401	7,210 New	7,210 $44,000
Q1 2020 May 15, 2020	SELL	$3.8 - $7.95 $3,560 - $7,449	-937 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$5.66 - $6.55 $5,303 - $6,137	937 New	937 $6,000

238K

Ticker IPHA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,893,000
Market Cap $141M
Description
Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.